Not applicableWithdrawnNCT03670134What this trial is testingPredict Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal MetaplasiaWho this might be right forBarrett Esophagus Mayo Clinic
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060What this trial is testingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more National Cancer Institute (NCI) 6,452
Testing effectiveness (Phase 2)UnknownNCT03544723What this trial is testingSafety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.Who this might be right forSolid TumorLymphoma MultiVir, Inc. 40
Early research (Phase 1)Study completedNCT00004879What this trial is testingMonoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction CancerWho this might be right forColorectal CancerEsophageal CancerKidney Cancer+3 more Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00217581What this trial is testingBevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction CancerWho this might be right forEsophageal CancerGastric Cancer Barbara Ann Karmanos Cancer Institute 39
Not applicableNot Yet RecruitingNCT07455422What this trial is testingBarrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect of Risk Profile Disclosure on Patient Quality of Life and Fear of CancerWho this might be right forBarrett EsophagusBarrett Esophagus AdenocarcinomaAdenocarcinoma - GEJ+2 more University Hospital, Antwerp 266
Early research (Phase 1)UnknownNCT00010270What this trial is testingLMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal CancerWho this might be right forColorectal CancerEsophageal CancerGastric Cancer+1 more University Hospital Freiburg 50
Not applicableActive Not RecruitingNCT07074535What this trial is testingCT and Endoscopic Biopsy Image-Based Deep Learning for Predicting Left Recurrent Laryngeal Nerve Lymph Node Metastasis in Esophageal CancerWho this might be right forEsophageal Squamous Cell Cancer (SCC)Recurrent Laryngeal Nerve PalsyDeep Learning+1 more Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05732662What this trial is testingSBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCCWho this might be right forRecurrent or Metastatic Esophageal Squamous Cell Carcinoma The First People's Hospital of Changzhou 25
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Post-approval studies (Phase 4)UnknownNCT01038154What this trial is testingStudy to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal CancerWho this might be right forEsophageal CancerStomach Cancer Hospital Donostia 146
Not applicableStudy completedNCT02385604What this trial is testingThe Predictive Value of CT-PET in Esophageal CancerWho this might be right forEsophageal Neoplasms St. James's Hospital, Ireland 250
Large-scale testing (Phase 3)Study completedNCT03143153What this trial is testingEvaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus CisplatinWho this might be right forVarious Advanced Cancer Bristol-Myers Squibb 970
Not applicableNot Yet RecruitingNCT04616040What this trial is testingA Real-world Study Evaluating the Usage of Camrelizumab in Chinese Patients With Advanced Esophageal CancerWho this might be right forEsophageal Cancer Peking University 1,030
Early research (Phase 1)Ended earlyNCT04187872What this trial is testingLITT and Pembrolizumab in Recurrent Brain MetastasisWho this might be right forMelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more University of Florida 10
Testing effectiveness (Phase 2)Study completedNCT03993353What this trial is testingTadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck CancerWho this might be right forHead and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Carcinoma+9 more University of California, San Diego 7
Testing effectiveness (Phase 2)Study completedNCT03322267What this trial is testingAdjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of RecurrenceWho this might be right forEsophageal Squamous Cell Carcinoma National Taiwan University Hospital 26
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT00313599What this trial is testingLapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsWho this might be right forBladder CancerBrain and Central Nervous System TumorsBreast Cancer+6 more University of California, San Francisco 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT07142421What this trial is testingTrifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) First Affiliated Hospital of Zhejiang University 35